A sterile implantable inner component of a two-piece acetabulum prosthesis that is inserted into an acetabular shell prosthesis to provide the articulating surface with a femoral head prosthesis as part of a total hip arthroplasty (THA). It is made of ceramic
| Company | Devices | Share |
|---|---|---|
| Smith & Nephew, Inc. | 80 | 68% |
| Depuy (Ireland) | 15 | 13% |
| Microport Orthopedics Inc. | 9 | 8% |
| Howmedica Osteonics Corp. | 6 | 5% |
| Encore Medical, L.P. | 5 | 4% |
| Limacorporate Spa | 2 | 2% |
Company = labeler of record on GUDID. 6 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| LPH | PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, POROUS UNC | 57 |
| MRA | Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Ceramic/Met | 42 |
| MRA | Prosthesis, hip, semi-constrained, metal/ceramic/ceramic/met | 31 |
| JDI | Prosthesis, hip, semi-constrained, metal/polymer, cemented | 10 |
| KWY | Prosthesis, hip, hemi-, femoral, metal/polymer, cemented or | 7 |
| MBL | Prosthesis, Hip, Semi-Constrained, Uncemented, Metal/Polymer | 2 |
Use these as the dimensions to specify in a tender line.
117 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Ceramic acetabular liner", from 6 companies. The largest labeler is Smith & Nephew, Inc. with 68% of records.
LPH (PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, POROUS UNC), MRA (Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Ceramic/Met), MRA (Prosthesis, hip, semi-constrained, metal/ceramic/ceramic/met), JDI (Prosthesis, hip, semi-constrained, metal/polymer, cemented)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add ceramic acetabular liner to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.